These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 15890989)

  • 1. Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry.
    Reeves MJ; Arora S; Broderick JP; Frankel M; Heinrich JP; Hickenbottom S; Karp H; LaBresh KA; Malarcher A; Mensah G; Moomaw CJ; Schwamm L; Weiss P;
    Stroke; 2005 Jun; 36(6):1232-40. PubMed ID: 15890989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Paul Coverdell National Acute Stroke Registry: initial results from four prototypes.
    Reeves MJ; Broderick JP; Frankel M; LaBresh KA; Schwamm L; Moomaw CJ; Weiss P; Katzan I; ; Arora S; Heinrich JP; Hickenbottom S; Karp H; Malarcher A; Mensah G; Reeves MJ
    Am J Prev Med; 2006 Dec; 31(6 Suppl 2):S202-9. PubMed ID: 17178304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paul Coverdell National Acute Stroke Registry Surveillance - four states, 2005-2007.
    George MG; Tong X; McGruder H; Yoon P; Rosamond W; Winquist A; Hinchey J; Wall HK; Pandey DK;
    MMWR Surveill Summ; 2009 Nov; 58(7):1-23. PubMed ID: 19893482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes in mild acute ischemic stroke treated with intravenous thrombolysis: a retrospective analysis of the Get With the Guidelines-Stroke registry.
    Romano JG; Smith EE; Liang L; Gardener H; Camp S; Shuey L; Cook A; Campo-Bustillo I; Khatri P; Bhatt DL; Fonarow GC; Sacco RL; Schwamm LH
    JAMA Neurol; 2015 Apr; 72(4):423-31. PubMed ID: 25642650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prioritizing interventions to improve rates of thrombolysis for ischemic stroke.
    California Acute Stroke Pilot Registry (CASPR) Investigators
    Neurology; 2005 Feb; 64(4):654-9. PubMed ID: 15728287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospital variation in thrombolysis times among patients with acute ischemic stroke: the contributions of door-to-imaging time and imaging-to-needle time.
    Sauser K; Levine DA; Nickles AV; Reeves MJ
    JAMA Neurol; 2014 Sep; 71(9):1155-61. PubMed ID: 25023407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.
    Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI
    Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Decade of Improvement in Door-to-Needle Time Among Acute Ischemic Stroke Patients, 2008 to 2017.
    Tong X; Wiltz JL; George MG; Odom EC; Coleman King SM; Chang T; Yin X; ; Merritt RK
    Circ Cardiovasc Qual Outcomes; 2018 Dec; 11(12):e004981. PubMed ID: 30557047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
    Seet RC; Rabinstein AA
    Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using recombinant tissue plasminogen activator to treat acute ischemic stroke in China: analysis of the results from the Chinese National Stroke Registry (CNSR).
    Wang Y; Liao X; Zhao X; Wang DZ; Wang C; Nguyen-Huynh MN; Zhou Y; Liu L; Wang X; Liu G; Li H; Wang Y;
    Stroke; 2011 Jun; 42(6):1658-64. PubMed ID: 21512182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telephonic guidance of systemic thrombolysis in acute ischemic stroke: safety outcome in rural hospitals.
    Vaishnav AG; Pettigrew LC; Ryan S
    Clin Neurol Neurosurg; 2008 May; 110(5):451-4. PubMed ID: 18353532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-level and hospital-level determinants of the quality of acute stroke care: a multilevel modeling approach.
    Reeves MJ; Gargano J; Maier KS; Broderick JP; Frankel M; LaBresh KA; Moomaw CJ; Schwamm L
    Stroke; 2010 Dec; 41(12):2924-31. PubMed ID: 20966407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.
    Schwamm LH; Ali SF; Reeves MJ; Smith EE; Saver JL; Messe S; Bhatt DL; Grau-Sepulveda MV; Peterson ED; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):543-9. PubMed ID: 24046398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the extended thrombolysis time window on the proportion of recombinant tissue-type plasminogen activator-treated stroke patients and on door-to-needle time.
    Minnerup J; Wersching H; Ringelstein EB; Schilling M; Schäbitz WR; Wellmann J; Berger K
    Stroke; 2011 Oct; 42(10):2838-43. PubMed ID: 21852612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombolytic therapy with intravenous recombinant tissue plasminogen activator in Japanese older patients with acute ischemic stroke: Fukuoka Stroke Registry.
    Matsuo R; Kamouchi M; Ago T; Hata J; Shono Y; Kuroda J; Wakisaka Y; Sugimori H; Kitazono T;
    Geriatr Gerontol Int; 2014 Oct; 14(4):954-9. PubMed ID: 24320947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous thrombolysis for acute ischemic stroke occurring during hospitalization for transient ischemic attack.
    Tsivgoulis G; Sharma VK; Mikulik R; Krogias C; Haršány M; Bavarsad Shahripour R; Athanasiadis D; Teoh HL; Piperidou C; Alexandrov AV
    Int J Stroke; 2014 Jun; 9(4):413-8. PubMed ID: 23981541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
    Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
    Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.